Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with a prior history of heart disease were at greater risk when treated with immune checkpoint inhibitors.
Can a person’s immune system help prevent two types of non-small-cell lung cancer? Here’s how Robert Keith, MD, hopes to find out.
A new report tracks the most prominent cancers for men and women and finds substantial racial disparities in cancer treatment.
A passion for improving cardiovascular health for people with cancer
About 1 in 1,000 pregnant women is diagnosed with cancer. Do newer treatments, such as immunotherapy, work in this group of patients?
Allergy meds were linked to longer survival among cancer patients treated with immune checkpoint inhibitors.
Women were at greater risk than men for symptomatic adverse events and hematologic events.
“It is a really important development for our patients."
People who received the combination lived longer without experiencing serious events, including their cancer returning.
In a small trial, Jemperli led to complete remission in people with a biomarker for deficient DNA repair.
People with melanoma can modify lifestyle factors such as diet, stress and the gut microbiome to improve treatment outcomes.
Microorganisms in the gut influence how the body responds to common cancer treatments, including immunotherapy.
Compared with men, women had a 34% greater likelihood of adverse events, especially if they received immunotherapy.
Two treatment approaches using donor or engineered NK cells led to remission in people with lymphoma and leukemia.
New insights into why men fail to mount as powerful an immune response to many cancers as women do.
Researchers explore the relationship between gut bacteria and the body’s response to CAR-T therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.